Ionis Pharmaceuticals | IONS - Selling And Administration Expenses


Ionis Pharmaceuticals reported $151M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Agios Pharmaceuticals USD 38.46M 4.51M Mar/2026
Alnylam Pharmaceuticals USD 282.51M 2.55M Mar/2026
Arrowhead Research USD 41.74M 4.28M Mar/2026
Astellas Pharma JPY 234.7B 12.92B Mar/2026
BioCryst Pharmaceuticals USD 95.78M 12.77M Dec/2025
BioMarin Pharmaceutical USD 258.28M 63.92M Mar/2026
Celltrion KRW 12.71B 237.27B Dec/2025
Cspc Pharmaceutical CNY 1.87B 95.62M Dec/2025
Deva Holding AS TRY 462.26M 48.18M Sep/2023
Divis Laboratories Ltd INR 3.4B 10M Jun/2025
Esperion Therapeutics USD 39.42M 456K Dec/2025
Exelixis USD 139.6M 16.58M Mar/2026
Halozyme Therapeutics USD 46.29M 18.35M Mar/2026
Ionis Pharmaceuticals USD 151M 21M Mar/2026
Kangmei Pharma CNY 237.06M 37.35M Mar/2026
Knight Therapeutics CAD 35.45M 4.43M Dec/2025
Laboratorios Farma EUR 35.32M 2.75M Jun/2025
Malin Corporation EUR 1.1M 400K Dec/2024
Medical Developments International AUD 2.84M 4.19M Dec/2025
Moderna USD 173M 135M Mar/2026
Nektar Therapeutics USD 10.17M 10.17M Dec/2025
Neuren Pharmaceuticals AUD 3.74M 2.5M Dec/2025
Neurocrine Biosciences USD 318.5M 16.7M Mar/2026
Novartis USD 3.14B 296M Mar/2026
Omeros USD 11.32M 2.48M Sep/2024
OPKO Health USD 50.52M 3.28M Dec/2025
Organigram Holdings CAD 7.73M 1.13M Dec/2025
Ovoca Bio EUR 632K 2.33M Jun/2025
Pfizer USD 2.92B 1.16B Mar/2026
Pharma Mar EUR 15.31M 2M Mar/2026
PTC Therapeutics USD 73.89M 13.31M Mar/2026
Qiagen NV USD 153.88M 10.77M Dec/2025
Regeneron Pharmaceuticals USD 647.7M 127.3M Mar/2026
Roche Holding CHF 7.28B 3.99B Dec/2025
Sarepta Therapeutics USD 54.03M 51.35M Mar/2026
Sartorius EUR 221.3M 500K Mar/2026
Sino Biopharmaceutical CNY 7.54B 2.23B Jun/2025
Tilray USD 24.85M 1.7M Sep/2025
Ultragenyx Pharmaceutical USD 88M 1000K Mar/2026
Vertex Pharmaceuticals USD 493.7M 6.7M Mar/2026
Zealand Pharma A/S 91.81M 99.04M Dec/2025
Zz Pientze Pharmaceu CNY 214.31M 42.4M Mar/2026